Dietary Fungal Glucosylceramide and Ceramide Reduce the Formation of Aberrant Crypt Foci in 1,2-Dimethylhydrazine-Treated Mice: Differences in the Role of Glucosylceramide and Ceramide
Dietary Fungal Glucosylceramide and Ceramide Reduce the Formation of Aberrant Crypt Foci in 1,2-Dimethylhydrazine-Treated Mice: Differences in the Role of Glucosylceramide and Ceramide
复制标题
DOI:
10.1021/acsfoodscitech.2c00290
复制
发表时间:
2023-01-02
期刊:
影响因子:
--
通讯作者:
Kinoshita,Mikio
中科院分区:
文献类型:
--
作者:
Yamashita,Shinji;Tsuruma,Tomoya;Kinoshita,Mikio
Glucosylceramide (GlcCer) is composed of a glucose moiety attached to ceramides (Cer). GlcCer was reported to reduce the intestinal impairmentsin vivoand suppressin vitrointestinal inflammation. In this study, to clarify the effect of GlcCer on intestinal impairmentsin vivo, we compared the effects of shiitake mushroom-derived GlcCer (fungal GlcCer) on the formation of aberrant crypt foci (ACF) and colon inflammation with those of fungal Cer having the same Cer moiety of the fungal GlcCer. Fungal GlcCer- or Cer-supplemented diets significantly suppressed ACF formation in 1,2-dimethylhydrazine (DMH)-treated mice. Dietary fungal GlcCer reduced the expression of inflammation-related cytokines and apoptosis-related proteins induced by DMH, whereas dietary fungal Cer hardly reduced their expression upon intestinal injuries. Furthermore, when fungal GlcCer was ingested to the mice, only a small amount of fungal Cer was detected in the feces. These results indicate that the ingested fungal GlcCer might be hardly metabolized to fungal Cer and the GlcCer itself might suppress ACF formation in DMH-treated mice by suppressing intestinal inflammation.